ARTBIO

Raised $132M in a Series B round, announced 29 July 2025.

Total raised: $132M

Latest round Series BCountry United StatesSector Health

Round

$132MSeries B, 29 July 2025

Advances AB001 into Phase 2 and expands lead-212 manufacturing and supply chain.

Amount: $132M
Stage: Series B
Announced: 29 July 2025
Lead: Sofinnova Investments
Other investors: B Capital, F-Prime, Omega Funds, Third Rock Ventures, Qatar Investment Authority, Alexandria Venture Investments
Use of funds: Advances AB001 into Phase 2 and expands lead-212 manufacturing and supply chain.
Checked: Announced by the company
Sources: ARTBIO raises $132M (date approx) biospace.com
ARTBIO raises $132M (date approx) techstartups.com

Company

Develops alpha radioligand cancer therapies, lead program in prostate cancer

Based in: Cambridge, United States
Sector: Health
Website: artbio.com ↗

Questions

How much has ARTBIO raised?

ARTBIO raised $132M in a Series B round, announced on 29 July 2025.

Who invested in ARTBIO?

Sofinnova Investments led. Investors include Sofinnova Investments, B Capital, F-Prime, Omega Funds, Third Rock Ventures and Qatar Investment Authority.